Ashley Lauren

@ash_mull3

UNCC '16

Joined January 2013

28 Following

62 Followers

465 Posts

Ashley Lauren @ash_mull3

over 4 years ago

Thanks for making it to the end of my CE recap! I hope this was informative to all the other pharmacists out there!

Ashley Lauren @ash_mull3

over 4 years ago

Treatment of SCLC can include combinations of surgery, radiation therapy, and systemic therapy. SCLC is highly sensitive to these therapies; however, most patients will eventually die of recurrent disease.

ash_mull3's tweet photo. Treatment of SCLC can include combinations of surgery, radiation therapy, and systemic therapy. SCLC is highly sensitive to these therapies; however, most patients will eventually die of recurrent disease. https://t.co/6VQEp6RFdD

Ashley Lauren @ash_mull3

over 4 years ago

In recent years, the IMpower133 trial and CASPIAN trial have shaped the NCCN Guidelines for SCLC treatment in extensive-stage disease, as summarized in the figure below. You may also start to see the use of a newer drug, lurbinectedin, in the setting relapsed/refractory disease.

$ash_mull3's tweet photo. In recent years, the IMpower133 trial and CASPIAN trial have shaped the NCCN Guidelines for SCLC treatment in extensive-stage disease, as summarized in the figure below. You may also start to see the use of a newer drug, lurbinectedin, in the setting relapsed/refractory disease. https://t.co/DLjT0YxGSW$

Ashley Lauren @ash_mull3

over 4 years ago

There are several symptoms associated with lung cancer, some of which are specific to the lung (such as cough or shortness of breath) while others are generalized (such as unexplained weight loss, weakness and fatigue).

Who to follow

Beagan Sterckx-Ziegler

@BeaganZ

Ashley Lauren @ash_mull3

over 4 years ago

Lung cancer is the third-most commonly diagnosed cancer in the U.S., yet it is by far the leading cause of cancer-related deaths each year. Unfortunately, the relative 5-year survival rate of lung cancer is roughly 20%.

ash_mull3's tweet photo. Lung cancer is the third-most commonly diagnosed cancer in the U.S., yet it is by far the leading cause of cancer-related deaths each year. Unfortunately, the relative 5-year survival rate of lung cancer is roughly 20%. https://t.co/Sr9JOjwZFm

Ashley Lauren @ash_mull3

over 4 years ago

I recently got to present my CE on updated treatment of small cell lung cancer (SCLC) at @baptistmemrxres! Here are some highlights from my presentation!